Hypertension and nephrology

[The main directions of treatment of obesity are described in VIII. Hungarian In the light of the Cardiovascular Consensus Conference]

SIMONYI Gábor1, BEDROS J. Róbert2,3,4

JUNE 24, 2021

Hypertension and nephrology - 2021;25(03)

DOI: https://doi.org/10.33668/hn.25.011

[The treatment of obesity is a complex process, the elements of which are lifestyle change (diet and exercise), psychic driving, medication and need in case of surgical treatment. The Hungarian Society of Obesitology and Movement Therapy the first half year of the weight loss program is low in carbs and elevated suggests a protein-rich diet. When designing physical activity, dynamic, aerobic (eg walking, walking, jogging, swimming, cycling, etc.) are recommended. In drug therapy, orlistat, naltrexone / bupropion, is fixed combination and liraglutide play a role. Bariatric surgery they are currently most effective in the short- and long-term treatment of obesity.]

AFFILIATIONS

  1. Szent Imre Egyetemi Oktatókórház, Anyagcsere Központ, Budapest
  2. Szent Imre Egyetemi Oktatókórház
  3. Országos Obezitológiai Centrum
  4. Magyar Obezitológiai és Mozgásterápiás Társaság, Budapest

COMMENTS

0 comments

Further articles in this publication

Hypertension and nephrology

[A new approach to renal osteodystrophy in the diagnosis and treatment of]

MÁCSAI Emília, SZLOVÁK Edina, DOLGOS Szilveszter

[Treatment of renal osteodystrophy (ROD) is one of the new osteoporosis recommendations requires a rethink of the current therapeutic approach. Addressing vitamin D deficiency and reducing quality of life deterioration caused by bone fractures it is also an important professional challenge in the renal insufficiency population. ROD is a classic nephrological treatment to improve the results of the newer molecular expected from better understanding of pathomechanisms and better imaging methods. Associated associations with vascular calcification are cardiovascular can help our efforts to prevent complications, a relationship with periodontal disease the importance of regular monitoring supports. In addition to phosphorus binders, vitamin D agonists and calcimimetics in the future is expected to be the resorption inhibitor denosumab, the bone-building processes supporting PTH analogues and the wider clinical use of romosozumab application.]

Hypertension and nephrology

[Threshold for drug treatment of hypertension target values ​​in the most important therapeutic guidelines]

KÉKES Ede, VÁLYI Péter, NAGY Judit

[Start medication and choose the right target are crucial today - with the aging of the world’s population together - the occurrence of high blood pressure, which is clearly considered a public disease in order to curb it. This also means that the recommendations are justified age-disaggregated and segregated between 18 and 65 years old, the elderly and the very elderly hypertensives. In the latter, it is not just prevalence rate has increased significantly, but also to be reckoned with the incidence of cognitive dysfunction, physical inactivity and common comorbidities, and also with side effects due to polypragmatism. We show it with all this in mind recommendations for the most important guidelines for the treatment of hypertension - also the Hungarian Hypertension Society -, pointing to the corresponding / similar guidelines.]

Hypertension and nephrology

[Welcome]

ALFÖLDI Sándor

Hypertension and nephrology

[Arteriovenous fistulas and grafts peri- and postoperative care in hemodialysis adults]

DOLGOS Szilveszter, SZLOVÁK Edina, HUSZÁR Liliána, FEKETE Alexandra, MÁCSAI Emília

[A well-designed blood collection site is suitable for hemodialysis (HD-) treatment basis. Even today, kidney replacement therapy is one of the biggest the challenge is to design the right place to bleed and its - during regular HD treatments - long-term preservation. If the previously established blood collection site is bad functioning, removal of uraemic end products would be insufficient the patient’s uraemic condition worsens and his typical symptoms develop Who. In case all is already possible blood site was exhausted, then hemodialysis itself nor can it be sustained further, which is rarely even kidney failure it can also lead to the death of a patient. Hemodialysis patients are hospitalized uptake is more than 20% related to the site of blood collection complications.]

Hypertension and nephrology

[Restart of physical activity after Covid-19]

VÁLYI Péter

All articles in the issue

Related contents

Clinical Neuroscience

Fluoxetine use is associated with improved survival of patients with COVID-19 pneumonia: A retrospective case-control study

NÉMETH Klára Zsófia, SZÛCS Anna , VITRAI József , JUHÁSZ Dóra , NÉMETH Pál János , HOLLÓ András

We aimed to investigate the association between fluoxetine use and the survival of hospitalised coronavirus disease (COVID-19) pneumonia patients. This retrospective case-control study used data extracted from the medical records of adult patients hospitalised with moderate or severe COVID-19 pneumonia at the Uzsoki Teaching Hospital of the Semmelweis University in Budapest, Hungary between 17 March and 22 April 2021. As a part of standard medical treatment, patients received anti-COVID-19 therapies as favipiravir, remdesivir, baricitinib or a combination of these drugs; and 110 of them received 20 mg fluoxetine capsules once daily as an adjuvant medication. Multivariable logistic regression was used to evaluate the association between fluoxetine use and mortality. For excluding a fluoxetine-selection bias potentially influencing our results, we compared baseline prognostic markers in the two groups treated versus not treated with fluoxetine. Out of the 269 participants, 205 (76.2%) survived and 64 (23.8%) died between days 2 and 28 after hospitalisation. Greater age (OR [95% CI] 1.08 [1.05–1.11], p<0.001), radiographic severity based on chest X-ray (OR [95% CI] 2.03 [1.27–3.25], p=0.003) and higher score of shortened National Early Warning Score (sNEWS) (OR [95% CI] 1.20 [1.01-1.43], p=0.04) were associated with higher mortality. Fluoxetine use was associated with an important (70%) decrease of mortality (OR [95% CI] 0.33 [0.16–0.68], p=0.002) compared to the non-fluoxetine group. Age, gender, LDH, CRP, and D-dimer levels, sNEWS, Chest X-ray score did not show statistical difference between the fluoxetine and non-fluoxetine groups supporting the reliability of our finding. Provisional to confirmation in randomised controlled studies, fluoxetine may be a potent treatment increasing the survival for COVID-19 pneumonia.

Clinical Neuroscience

Evaluation of the effectiveness of transforaminal epidural steroid injection in far lateral lumbar disc herniations

EVRAN Sevket, KATAR Salim

Far lateral lumbar disc herniations (FLDH) consist approximately 0.7-12% of all lumbar disc herniations. Compared to the more common central and paramedian lumbar disc herniations, they cause more severe and persistent radicular pain due to direct compression of the nerve root and dorsal root ganglion. In patients who do not respond to conservative treatments such as medical treatment and physical therapy, and have not developed neurological deficits, it is difficult to decide on surgical treatment because of the nerve root damage and spinal instability risk due to disruption of facet joint integrity. In this study, we aimed to evaluate the effect of transforaminal epidural steroid injection (TFESI) on the improvement of both pain control and functional capacity in patients with FLDH. A total of 37 patients who had radicular pain caused by far lateral disc herniation which is visible in their lumbar magnetic resonance imaging (MRI) scan, had no neurological deficit and did not respond to conservative treatment, were included the study. TFESI was applied to patients by preganglionic approach. Pre-treatment Visual Analogue Scale (VAS) and Oswestry Disability Index (ODI) scores of the patients were compared with the 3rd week, 3rd month and 6th month scores after the procedure. The mean initial VAS score was 8.63 ± 0.55, while it was 3.84 ± 1.66, 5.09 ± 0.85, 4.56 ± 1.66 at the 3rd week, 3rd month and 6th month controls, respectively. This decrease in the VAS score was found statistically significant (p = 0.001). ODI score with baseline mean value of 52.38 ± 6.84 was found to be 18.56 ± 4.95 at the 3rd week, 37.41 ± 14.1 at the 3rd month and 34.88 ± 14.33 at the 6th month. This downtrend of pa­tient’s ODI scores was found statistically significant (p = 0.001). This study has demonstrated that TFESI is an effective method for gaining increased functional capacity and pain control in the treatment of patients who are not suitable for surgical treatment with radicular complaints due to far lateral lumbar disc hernia.

Lege Artis Medicinae

[LAM 30: 1990–2020. Facing the mirror: Three decades of LAM, the Hungarian medicine and health care system]

KAPÓCS Gábor

Clinical Neuroscience

Comparison of direct costs of percutaneous full-endoscopic interlaminar lumbar discectomy and microdiscectomy: Results from Turkey

ÜNSAL Ünlü Ülkün, ŞENTÜRK Salim

Microdiscectomy (MD) is a stan­dard technique for the surgical treatment of lumbar disc herniation (LDH). Uniportal percutaneous full-endoscopic in­terlaminar lumbar discectomy (PELD) is another surgical op­tion that has become popular owing to reports of shorter hos­pitalization and earlier functional recovery. There are very few articles analyzing the total costs of these two techniques. The purpose of this study was to compare total hospital costs among microdiscectomy (MD) and uniportal percutaneous full-endoscopic interlaminar lumbar discectomy (PELD). Forty patients aged between 22-70 years who underwent PELD or MD with different anesthesia techniques were divided into four groups: (i) PELD-local anesthesia (PELD-Local) (n=10), (ii) PELD-general anesthesia (PELD-General) (n=10), (iii) MD-spinal anesthesia (MD-Spinal) (n=10), (iv) MD-general anesthesia (MD-General) (n=10). Health care costs were defined as the sum of direct costs. Data were then analyzed based on anesthetic modality to produce a direct cost evaluation. Direct costs were compared statistically between MD and PELD groups. The sum of total costs was $1,249.50 in the PELD-Local group, $1,741.50 in the PELD-General group, $2,015.60 in the MD-Spinal group, and $2,348.70 in the MD-General group. The sum of total costs was higher in the MD-Spinal and MD-General groups than in the PELD-Local and PELD-General groups. The costs of surgical operation, surgical equipment, anesthesia (anesthetist’s costs), hospital stay, anesthetic drugs and materials, laboratory wor­kup, nur­sing care, and postoperative me­dication diffe­red significantly among the two main groups (PELD-MD) (p<0.01). This study demonstrated that PELD is less costly than MD.

Clinical Neuroscience

Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias

BALÁZS Nóra , BERECZKI Dániel, KOVÁCS Tibor

In aging societies, the morbidity and mortality of dementia is increasing at a significant rate, thereby imposing burden on healthcare, economy and the society as well. Patients’ and caregivers’ quality of life and life expectancy are greatly determined by the early diagnosis and the initiation of available symptomatic treatments. Cholinesterase inhibitors and memantine have been the cornerstones of Alzheimer’s therapy for approximately two decades and over the years, more and more experience has been gained on their use in non-Alzheimer’s dementias too. The aim of our work was to provide a comprehensive summary about the use of cholinesterase inhibitors and memantine for the treatment of Alzheimer’s and non-Alzheimers’s dementias.